Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Recruiting

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

NCT07479485

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Beijing You An Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • The Ethics Committee of Cancer Hospital Chinese Academy of Medical Sciences. Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou, Fujian, China
View Trial Details
Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.

NCT07607769

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Research site Ancona, Italy
  • Research Site Ancona, Italy
  • Research Site Bergamo, Italy
  • Research site Foggia, Italy
View all 24 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

NCT06811116

Conditions
Adenocarcinoma, Advanced Hepatocellular Carcinoma, Carcinoma, +12 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06910657

Conditions
Adenocarcinoma, Adnexal Diseases, Adrenal Gland Diseases, +94 more
Locations
  • Washington University School of Medicine St Louis, Missouri, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics San Antonio, Texas, United States
  • Westmead Hospital Westmead, New South Wales, Australia
View Trial Details
Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

NCT07291076

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Local Institution - 0137 Duarte, California, United States
  • Local Institution - 0070 Los Angeles, California, United States
  • Local Institution - 0107 Chicago, Illinois, United States
  • Local Institution - 0134 Detroit, Michigan, United States
View all 64 locations
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details

Related conditions